Köster Claudia, Pohl Sebastian, Kleinebudde Peter
Institute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University, Universitätsstr. 1, 40225 Duesseldorf, Germany.
Pharmaceutics. 2021 Feb 9;13(2):241. doi: 10.3390/pharmaceutics13020241.
The binders povidone (Kollidon 30), copovidone (Kollidon VA64), hypromellose (Pharmacoat 606), and three types of hyprolose (HPC SSL‑SFP, HPC SSL, and HPC SL‑FP) were evaluated regarding their suitability in twin-screw wet granulation. Six mixtures of lactose and binder as well as lactose without binder were twin-screw granulated with demineralized water at different barrel fill levels and subsequently tableted. A screening run with HPC SSL determined the amount of water as an influential parameter for oversized agglomerates. Subsequent examination of different binders, especially Kollidon 30 and Kollidon VA64 resulted in large granules. All binders, except Pharmacoat 606, led to a reduction of fines compared to granulation without a binder. The molecular weight of applied hyproloses did not appear as influential. Tableting required an upstream sieving step to remove overlarge granules. Tableting was possible for all formulations at sufficient compression pressure. Most binders resulted in comparable tensile strengths, while Pharmacoat 606 led to lower and lactose without a binder to the lowest tensile strength. Tablets without a binder disintegrated easily, whereas binder containing tablets of sufficient tensile strength often nearly failed or failed the disintegration test. Especially tablets containing Pharmacoat 606 and HPC SL‑FP disintegrated too slowly.
对黏合剂聚维酮(聚乙烯吡咯烷酮30)、共聚维酮(聚乙烯聚维酮VA64)、羟丙甲纤维素(羟丙基甲基纤维素606)以及三种羟丙基纤维素(羟丙基纤维素SSL-SFP、羟丙基纤维素SSL和羟丙基纤维素SL-FP)在双螺杆湿法制粒中的适用性进行了评估。将乳糖与黏合剂的六种混合物以及不含黏合剂的乳糖与去离子水在不同料筒填充水平下进行双螺杆制粒,随后压片。用羟丙基纤维素SSL进行的初步试验确定了水的量是影响超大团聚体形成的一个参数。随后对不同黏合剂,特别是聚乙烯吡咯烷酮30和聚乙烯聚维酮VA64进行的研究产生了大颗粒。除羟丙基甲基纤维素606外,所有黏合剂与无黏合剂制粒相比均导致细粉减少。所用羟丙基纤维素的分子量似乎没有影响。压片需要上游筛分步骤以去除过大颗粒。在足够的压缩压力下,所有制剂均可压片。大多数黏合剂产生的抗张强度相当,而羟丙基甲基纤维素606产生的抗张强度较低,无黏合剂的乳糖产生的抗张强度最低。无黏合剂的片剂易于崩解,而具有足够抗张强度的含黏合剂片剂在崩解试验中往往几乎不合格或不合格。特别是含有羟丙基甲基纤维素606和羟丙基纤维素SL-FP的片剂崩解过慢。